World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
40689
World Ranking
8520
National Ranking
836

Mark J. Millan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark J. Millan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 447 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark J. Millan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark J. Millan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark J. Millan is affiliated with the University of Glasgow in the United Kingdom. Their research spans multiple fields with a focus on Medicine, Neuroscience, and Biochemistry, Genetics and Molecular Biology. Within these domains, their work primarily explores Cellular and Molecular Neuroscience, Molecular Biology, Pharmacology, Physiology, and Biochemistry.

The scientist's major topics of study revolve around Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, and the Treatment of Major Depression. Other notable areas include Alzheimer's disease research and treatments, Neurotransmitter Receptor Influence on Behavior, Tryptophan and brain disorders, as well as Neuropeptides and Animal Physiology.

Notable recent papers authored or coauthored by Millan include:

  • Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action, 2022, Therapeutic Advances in Psychopharmacology
  • Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs, 2020, Neuropharmacology

Other influential works from related fields include "Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing" published in 2020 in Nature Reviews Drug Discovery, and "Prevention of Psychosis" published in 2020 in JAMA Psychiatry.

Frequent coauthors associated with Millan's research include Clotilde Mannoury la Cour, Ross Jeggo, Per Svenningsson, David J. Watson, and K.C.F. Fone, with multiple collaborations ranging from three to four joint publications each.

The scientist regularly publishes in venues such as the International Journal of Molecular Sciences, Neuroscience Applied, Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature, Nature Reviews Drug Discovery, and JAMA Psychiatry.

Best Publications

  • Descending control of pain.

    Mark J. Millan

  • The induction of pain: an integrative review

    Mark J. Millan

  • Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

    Mark J. Millan;Yves Agid;Martin Brüne;Edward T. Bullmore

  • The neurobiology and control of anxious states

    Mark J. Millan

  • Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

    Stephen C. Cunnane;Eugenia Trushina;Cecilie Morland;Alessandro Prigione

  • Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

    Mark J. Millan

  • The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

    Mark J. Millan;Alain Gobert;Françoise Lejeune;Anne Dekeyne

  • Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

    Mark J. Millan;Lisa Maiofiss;Didier Cussac;Valérie Audinot

  • Altering the course of schizophrenia: progress and perspectives

    Mark J. Millan;Annie Andrieux;George Bartzokis;Kristin Cadenhead

  • Agomelatine, the first melatonergic antidepressant: discovery, characterization and development.

    Christian de Bodinat;Béatrice Guardiola-Lemaitre;Elisabeth Mocaër;Pierre Renard

  • Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

    Alain Gobert;Jean‐Michel Rivet;Françoise Lejeune;Adrian Newman‐Tancredi

  • Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing

    Barry Boland;Wai Haung Yu;Olga Corti;Bertrand Mollereau

  • Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention

    Paolo Fusar-Poli;Gonzalo Salazar de Pablo;Gonzalo Salazar de Pablo;Christoph U. Correll;Andreas Meyer-Lindenberg

  • Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)1A Receptors

    Mark J. Millan

  • Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

    Mark J. Millan;Kevin Fone;Thomas Steckler;William P. Horan

  • Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions.

    Mark J Millan;Philippe Marin;Philippe Marin;Joëel Bockaert;Joëel Bockaert;Clotilde Mannoury la Cour

  • Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk

    P. Fusar-Poli;M. Tantardini;S. De Simone;V. Ramella-Cravaro

  • The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review.

    Mark J. Millan

  • Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade

    Mark J. Millan;Mauricette Brocco;Alain Gobert;Anne Dekeyne

  • Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents.

    Mark J. Millan;Françoise Lejeune;Alain Gobert

Frequent Co-Authors

Alain P. Gobert
Alain P. Gobert Vanderbilt University Medical Center
Jean A. Boutin
Jean A. Boutin Institut de Recherches Internationales Servier
Berend Olivier
Berend Olivier Utrecht University
Michael Spedding
Michael Spedding DuPont (United States)
Pierre Sokoloff
Pierre Sokoloff Grenoble Alpes University
Joël Bockaert
Joël Bockaert University of Montpellier
Philippe Marin
Philippe Marin University of Montpellier
Jean-Daniel Brion
Jean-Daniel Brion Centre national de la recherche scientifique, CNRS
Per Svenningsson
Per Svenningsson Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers beyond traditional MD programs, a variety of online degrees offer flexible and diverse pathways. Exploring related fields can open doors in healthcare leadership, advanced nursing, and mental health services.

Nurses seeking to specialize in psychiatric care can benefit from online msn pmhnp programs, which prepare graduates for advanced practice roles in mental health. Meanwhile, those interested in the administrative side of healthcare can find rewarding opportunities through healthcare administration degrees. These programs focus on hospital management, policy, and organizational leadership.

Ambitious students looking to advance further may consider a graduate degree, such as the most affordable online mha programs. These programs teach strategic management skills for leading healthcare organizations. For nursing professionals seeking the highest level of clinical expertise, cheap dnp online programs offer a cost-effective way to attain a Doctor of Nursing Practice degree.

Exploring these alternative online degrees can provide more options for entering and advancing in the fast-growing healthcare sector.

Best Scientists Citing Mark J. Millan

Trending Scientists

Recently Published Articles